Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Innovation
Share your love
2023 Recap: Top 20 Ophthalmic Collaborations of the Year
As we bid farewell to 2023, it’s time to reflect on the remarkable collaborations that have shaped the landscape of ophthalmic innovation. The past year witnessed groundbreaking partnerships between pharmaceutical giants, tech innovators, and research institutions, all aimed at advancing…
2023 Recap: Top 15 Ophthalmic Medical Devices
In a groundbreaking year for ophthalmic advancements, 2023 has witnessed the launch of cutting-edge medical devices that promise to reshape the landscape of eye care. From augmented reality headsets to innovative surgical systems, the field is experiencing a wave of…
GRF Allocates $2.5M Grant for Glaucoma Research
The Glaucoma Research Foundation (GRF) announced an unprecedented $2.5 million allocation in annual research grants, marking the most significant investment in its 46-year history dedicated to pioneering efforts towards treating glaucoma and vision loss. Understanding Glaucoma and Its Impact Glaucoma…
AI Detects Retinopathy of Prematurity with 100% Accuracy
In a study published in JAMA Ophthalmology, researchers from Oregon Health & Science University (OHSU) alongside international collaborators have unveiled an artificial intelligence (AI) technology capable of independently detecting all severe cases of a condition leading to blindness in prematurely…
Amring Pharma Announces Name Change to Nordic Pharma
In a significant corporate rebranding, Amring Pharmaceuticals has officially adopted the name Nordic Pharma. This renaming marks a new chapter following the acquisition by Nordic Group, a subsidiary of Sever Life Sciences, on June 1, 2023. The strategic move aims…
Optos Celebrates Worldwide Installations & Clinical Studies
Optos PLC celebrates two significant achievements: the global installation of over 25,000 devices and the accomplishment of 2,500 clinical and peer-reviewed studies covering 235 disease states. These milestones underscore Optos’ over three decades of innovation and its substantial impact on elevating…
VSY Biotechnology Aims for Great Place to Work® Certification
VSY Biotechnology GmbH, a leader in the biotechnology sector based in Leinfelden-Echterdingen, Germany, announced a key strategic partnership with Great Place to Work®, the worldwide authority on workplace culture and employee satisfaction. This collaboration is a testament to VSY Biotechnology’s…
Eversight Partners with Emmecell for Ocular Therapy Advances
Eversight, a leading non-profit dedicated to the restoration of sight through the recovery, processing, and distribution of corneal tissue, announced a strategic partnership with Emmecell Biotech, a biotechnology company focused on developing novel cell therapies for ocular diseases. This collaboration…
MACUSTAR Extends Systematic AMD Research
The MACUSTAR consortium, led by the Department of Ophthalmology at the University Hospital Bonn (UKB), is extending its Europe-wide clinical study on age-related macular degeneration (AMD). The primary focus of the extension is to garner further insights into the intermediate…
Lupin Launches Bromfenac Ophthalmic Solution in the US
Lupin Limited announced the launch of Bromfenac Ophthalmic Solution, 0.075%. The product has received the green light from the United States Food and Drug Administration (U.S. FDA), marking a crucial milestone for the company’s expansion in the American pharmaceutical market.…